Real Brokerage (REAX) Form 144: Laurence Rose Discloses Recent Insider Sales
Rhea-AI Filing Summary
Form 144 filed for Real Brokerage Inc (REAX) reports a proposed sale of 1,219 common shares through Morgan Stanley Smith Barney with an aggregate market value of $6,107.19, to be sold on 09/18/2025 on NASDAQ. The shares were acquired the same day via stock option exercise and paid in cash. The filer, Laurence Rose, also disclosed two prior sales within the past three months: 151,596 shares on 08/12/2025 for $635,650.00 and 50,000 shares on 06/23/2025 for $200,264.00. The notice includes the required representation that no undisclosed material adverse information is known.
Positive
- Compliance disclosure filed for proposed sale under Rule 144 with broker and execution details
- Prior sales disclosed for the past three months, showing transparency of insider transactions
Negative
- Significant insider sales disclosed in the past three months (151,596 and 50,000 shares) which may be material to holders
- Form lacks issuer financial or contextual information beyond the sales and acquisition details
Insights
TL;DR: Insider intends to sell 1,219 shares acquired via option exercise; recent large insider sales are disclosed.
The filing documents a routine Rule 144 notice for the sale of 1,219 shares acquired by stock option exercise and paid for in cash, with a nominal aggregate value of $6,107.19 scheduled on 09/18/2025. Material context provided by the filer shows significant dispositions in the prior three months: 151,596 shares and 50,000 shares, with gross proceeds listed. From a reporting perspective, the form appears complete for the proposed sale and prior sales disclosure; it meets the procedural requirements of Rule 144.
TL;DR: Filing is a compliance disclosure of insider sales; prior large sales are documented but no additional corporate details are provided.
The document provides the necessary attestations and signature notice required under Rule 144. It specifies the relationship of the seller and identifies the broker and execution venue. The filing does not include any statement of undisclosed material adverse information by the filer. No governance actions, policy changes, or additional issuer-specific information are included in this notice.